Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1553442

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1553442

New York Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC, Others), By Cultivation (Indoor Cultivation, Greenhouse Cultivation), By End-use, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

New York Legal Cannabis Market Growth & Trends:

The New York legal cannabis market size is expected to reach USD 3.22 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the legalization of medicinal cannabis, rising consumer disposable income, increasing consumer awareness of the health benefits of cannabis, growing demand for cannabis from the pharmaceutical industry, and the approval of the U.S. Farm Bill are expected to boost market growth.

Cannabis is utilized for managing a range of ailments, including mental health issues, cancer, nausea, and pain, and for adult use purposes. The increasing prevalence of cancer is expected to significantly contribute to the increasing acceptance of medical marijuana over the forecast period. For instance, according to data published by the Government of New York, annually 116,000 New Yorkers are diagnosed with cancer.

The growing awareness among people regarding the therapeutic benefits of cannabis and the rise in cannabis certification educational and training programs fuel market growth. For instance, the travelling training program is a part of the New York State Cannabis Workforce Initiative. It's a collaboration between Cornell University's School of Industrial & Labor Relations and the non-profit Workforce Development Institute, which is partly funded by the state. This program has successfully educated hundreds of individuals in the fundamental aspects of the cannabis industry.

Moreover, the increase in research activities related to cannabis is driving the market growth. In August 2023, regulations for Cannabis Research Licenses were implemented. These regulations allow licensed researchers to cultivate, process, purchase, and possess cannabis for the purpose of testing its composition levels and chemical potency, studying the safety and effectiveness of cannabis as a medical treatment, conducting agricultural or genomic research, as well as carrying out clinical studies of cannabis-derived drug products.

New York Legal Cannabis Market Report Highlights:

  • Based on source, the marijuana segment accounted for the largest revenue share in 2023, owing to the growing research studies on cannabis for its medical use
  • Based on derivatives, the CBD segment dominated the market with the largest revenue share in 2023, owing to the growing adoption of CBD-infused medication, food, and cosmetics
  • Based on cultivation, the indoor cultivation segment accounted for the largest revenue share in 2023, owing to favorable government regulations and a rise in the number of cannabis cultivators
  • Based on end-use, the recreational use segment held the largest market share in 2023 due to the rise in the number of consumers adopting cannabis consumption in the form of smoking and vaping
Product Code: GVR-3-68038-420-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source
    • 1.2.2. Derivatives
    • 1.2.3. Cultivation
    • 1.2.4. End-use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Source outlook
    • 2.2.2. Derivatives outlook
    • 2.2.3. Cultivation outlook
    • 2.2.4. End Use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. New York Legal Cannabis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Case Study Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Landscape

Chapter 4. New York Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Source Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4. Hemp
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Hemp Oil
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Industrial Hemp
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Marijuana
    • 4.5.1. Market estimates and forecasts, 2018 to 2030, (USD Million)
    • 4.5.2. Flower
      • 4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Oil and Tinctures
      • 4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. New York Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Derivatives Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. CBD
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. THC
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. New York Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Cultivation Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Indoor Cultivation
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Greenhouse Cultivation
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Outdoor Cultivation
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. New York Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4. Industrial Use
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Medical Use
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. Chronic Pain
      • 7.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Depression and Anxiety
      • 7.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Arthritis
      • 7.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Post Traumatic Stress Disorder (PTSD)
      • 7.5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Cancer
      • 7.5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Migraines
      • 7.5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Epilepsy
      • 7.5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Alzheimer's
      • 7.5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.10. Multiple Sclerosis
      • 7.5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.11. Amyotrophic Lateral Sclerosis
      • 7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.12. Tourette's
      • 7.5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.13. Diabetes
      • 7.5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.14. Parkinson's
      • 7.5.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.15. Glaucoma
      • 7.5.15.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.16. Others
      • 7.5.16.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Recreational Use
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Position Analysis
  • 8.4. Company Profiles
    • 8.4.1. Curaleaf Holdings, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Service Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. New York Hemp Oil
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Service Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. COOKIES CREATIVE PRODUCTIONS & CONSULTING, INC.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Service Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. ACREAGE HOLDINGS.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Service Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Cannabist Company Holdings Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Service Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Cresco Labs
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Service Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. PharmaCann Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Service Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Canna West Seattle
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Service Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Vireo Health International, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Service Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Green Thumb Industries (GTI)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Service Benchmarking
      • 8.4.10.4. Strategic Initiatives
Product Code: GVR-3-68038-420-8

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 New York legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 4 New York legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 5 New York legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
  • Table 6 New York legal cannabis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market research approaches
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. cannabis market: market outlook
  • Fig. 9 U.S. cannabis competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Industry value chain analysis
  • Fig. 13 New York legal cannabis market driver impact
  • Fig. 14 New York legal cannabis market restraint impact
  • Fig. 15 New York legal cannabis market strategic initiatives analysis
  • Fig. 16 New York legal cannabis market: Source movement analysis
  • Fig. 17 New York legal cannabis market: Source outlook and key takeaways
  • Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
  • Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
  • Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
  • Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
  • Fig. 22 Flower market estimates and forecasts, 2018 - 2030
  • Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
  • Fig. 24 New York legal cannabis market: Derivatives movement analysis
  • Fig. 25 New York legal cannabis market: Derivatives outlook and key takeaways
  • Fig. 26 CBD market estimates and forecasts, 2018 - 2030
  • Fig. 27 THC market estimates and forecasts, 2018 - 2030
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030
  • Fig. 29 New York legal cannabis market: Cultivation movement analysis
  • Fig. 30 New York legal cannabis market: Cultivation outlook and key takeaways
  • Fig. 31 Indoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 33 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
  • Fig. 34 New York legal cannabis market: End Use movement analysis
  • Fig. 35 New York legal cannabis market: End Use outlook and key takeaways
  • Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
  • Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
  • Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
  • Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
  • Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
  • Fig. 41 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
  • Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
  • Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
  • Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
  • Fig. 45 Alzheimer's market estimates and forecasts, 2018 - 2030
  • Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
  • Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
  • Fig. 49 Tourette's market estimates and forecasts, 2018 - 2030
  • Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
  • Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
  • Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030
  • Fig. 54 Recreational Use market estimates and forecasts, 2018 - 2030
  • Fig. 55 Key company categorization
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!